VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

MDS 2020 | Future treatment priorities for high-risk MDS

Yishai Ofran, MD, Rambam Health Care Campus, Haifa, Israel, discusses the future research priorities in the myelodysplastic syndromes (MDS) field. Specifically, novel agents that decrease the inflammation process within the bone marrow. This interview took place at the 2nd Regional Symposium on Myelodysplastic Syndromes (MDS 2020), held in Tel Aviv, Israel.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter